Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells

Endometrial cancers expressing estrogen and progesterone receptors respond to hormonal therapy. The disappearance of steroid hormone receptor expression is common in patients with recurrent disease, ultimately hampering the clinical utility of hormonal therapy. Here, we demonstrate for the first tim...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Lin, Chiao-Yun, Chao, Angel, Wang, Tzu-Hao, Lee, Li-Yu, Yang, Lan-Yan, Tsai, Chia-Lung, Wang, Hsin-Shih, Lai, Chyong-Huey
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5312367/
https://ncbi.nlm.nih.gov/pubmed/27527851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11048
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items